Please login to the form below

Not currently logged in
Email:
Password:

EMA’s Paediatric Committee elects new leaders

Dirk Mentzer and Henk van den Berg elected as chair and vice-chair

Dirk Mentzer The European Medicines Agency's (EMA) Paediatric Committee (PDCO) last week elected Dirk Mentzer and Henk van den Berg chair and vice-chair, respectively, at its September meeting. Both have been elected for a three-year term. 

A paediatrician by training, Dr Mentzer is currently head of the pharmacovigilance unit at the Paul-Ehrlich Institut in Frankfurt, Germany.  He is an expert in paediatric specialist training, including neonatology and paediatric accident and emergency admissions. 

Dr Van den Berg is a consultant in paediatric haematology / oncology at the Medicines Evaluation Board in Utrecht, the Netherlands.  His areas of expertise include paediatric haematology, clinical pharmacology and medical education. 

On their election, Mentzer and van den Berg thanked outgoing chair Daniel Brasseur, who has left the PDCO to become a member of the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP).

Both Mentzer and van den Berg have been members of the PDCO since it was established in 2007. The committee's main role is to assess the content of paediatric investigation plans (PIPS). It meets for three days each month at the EMA in London.

19th September 2013

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics